Collaboration is crucial when it comes to developing drug therapies for rare diseases. Nan Doyle, Adam Sherman, and Onno Faber discuss how a patient is able to be involved in every step of the process, and what pharmaceutical companies and researchers can do to form trust in these collaborative partnerships.